Literature DB >> 9576758

The agent of Human Granulocytic Ehrlichiosis resides in an endosomal compartment.

P Webster1, J W IJdo, L M Chicoine, E Fikrig.   

Abstract

The composition of cytoplasmic vacuoles containing the agent of Human Granulocytic Ehrlichiosis (HGE) was studied to investigate how this pathogen exists within infected host cells. Electron microscopy demonstrated that the HGE organism resides in a membrane-bound compartment within HL-60 cells: early forms of the HGE agent have a round reticular appearance while later structures are small and dense. Vacuoles containing HGE bacteria incorporated endocytosed colloidal gold particles, suggesting that they are part of the endocytic pathway. Antibodies directed to the mannose-6-phosphate receptor labeled vacuole membranes. Antibodies to the transferrin receptor and to the lysosomal membrane glycoprotein LAMP 1 did not. Moreover, 3-(2,4-dinitroanilino)-3'-amino-N-methyldipropylamine, which normally accumulates in compartments with low pH, was not present inside these vacuoles. These results suggest that vacuoles containing the agent of HGE fail to mature into phagolysosomes. We conclude that the agent of HGE appears to enter and modify part of the endocytic pathway.

Entities:  

Mesh:

Year:  1998        PMID: 9576758      PMCID: PMC508780          DOI: 10.1172/JCI1544

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

1.  A T. cruzi-secreted protein immunologically related to the complement component C9: evidence for membrane pore-forming activity at low pH.

Authors:  N W Andrews; C K Abrams; S L Slatin; G Griffiths
Journal:  Cell       Date:  1990-06-29       Impact factor: 41.582

2.  Some characteristics of heavy and light bands of Rickettsia prowazekii on Renografin gradients.

Authors:  B A Hanson; C L Wisseman; A Waddell; D J Silverman
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.441

3.  A new method of preparing gold probes for multiple-labeling cytochemistry.

Authors:  J W Slot; H J Geuze
Journal:  Eur J Cell Biol       Date:  1985-07       Impact factor: 4.492

4.  Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease.

Authors:  S M Chen; J S Dumler; J S Bakken; D H Walker
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

5.  Lack of lysosomal fusion with phagosomes containing Ehrlichia risticii in P388D1 cells: abrogation of inhibition with oxytetracycline.

Authors:  M Y Wells; Y Rikihisa
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

6.  Visualization of acidic organelles in intact cells by electron microscopy.

Authors:  R G Anderson; J R Falck; J L Goldstein; M S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

7.  Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging?

Authors:  J S Bakken; J S Dumler; S M Chen; M R Eckman; L L Van Etta; D H Walker
Journal:  JAMA       Date:  1994-07-20       Impact factor: 56.272

8.  Putative adhesins of Anaplasma marginale: major surface polypeptides 1a and 1b.

Authors:  D J McGarey; A F Barbet; G H Palmer; T C McGuire; D R Allred
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

9.  Lipid metabolism in Chlamydia trachomatis-infected cells: directed trafficking of Golgi-derived sphingolipids to the chlamydial inclusion.

Authors:  T Hackstadt; M A Scidmore; D D Rockey
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

10.  Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited.

Authors:  D L Clemens; M A Horwitz
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

View more
  31 in total

1.  Ehrlichia chaffeensis and E. sennetsu, but not the human granulocytic ehrlichiosis agent, colocalize with transferrin receptor and up-regulate transferrin receptor mRNA by activating iron-responsive protein 1.

Authors:  R E Barnewall; N Ohashi; Y Rikihisa
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Anaplasma phagocytophilum modulates gp91phox gene expression through altered interferon regulatory factor 1 and PU.1 levels and binding of CCAAT displacement protein.

Authors:  Venetta Thomas; Swapna Samanta; Caiyun Wu; Nancy Berliner; Erol Fikrig
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

3.  Early transcriptional response of human neutrophils to Anaplasma phagocytophilum infection.

Authors:  Bindu Sukumaran; Jason A Carlyon; Ji-Lian Cai; Nancy Berliner; Erol Fikrig
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

Review 4.  Type IV secretion in the obligatory intracellular bacterium Anaplasma phagocytophilum.

Authors:  Yasuko Rikihisa; Mingqun Lin; Hua Niu
Journal:  Cell Microbiol       Date:  2010-07-28       Impact factor: 3.715

Review 5.  Mechanisms of obligatory intracellular infection with Anaplasma phagocytophilum.

Authors:  Yasuko Rikihisa
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

6.  Granulocytic ehrlichiosis in mice deficient in phagocyte oxidase or inducible nitric oxide synthase.

Authors:  R Banerjee; J Anguita; E Fikrig
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

7.  Subversion of NPC1 pathway of cholesterol transport by Anaplasma phagocytophilum.

Authors:  Qingming Xiong; Yasuko Rikihisa
Journal:  Cell Microbiol       Date:  2012-02-08       Impact factor: 3.715

8.  Neutrophil NADPH oxidase is reduced at the Anaplasma phagocytophilum phagosome.

Authors:  Jacob W IJdo; Angel C Mueller
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

Review 9.  Molecular events involved in cellular invasion by Ehrlichia chaffeensis and Anaplasma phagocytophilum.

Authors:  Yasuko Rikihisa
Journal:  Vet Parasitol       Date:  2009-09-19       Impact factor: 2.738

10.  Anaplasma phagocytophilum utilizes multiple host evasion mechanisms to thwart NADPH oxidase-mediated killing during neutrophil infection.

Authors:  Jason A Carlyon; Dalia Abdel-Latif; Marc Pypaert; Paige Lacy; Erol Fikrig
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.